Recurrent High Risk Gastrointestinal Stromal Tumor of the Stomach with Long-term Survival after Five Curative Resections and Treatment with Imatinib Mesylate | Zendy

AI Assistant Blog Pricing

Recurrent High Risk Gastrointestinal Stromal Tumor of the Stomach with Long-term Survival after Five Curative Resections and Treatment with Imatinib Mesylate

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.